ArticleEuropean journal of public health2026
A decade of change in age, sex distribution, and comorbidities of obstructive sleep apnoea in Finland.
Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
There is limited information on changes over time in the incidence, age, sex, and comorbidities of obstructive sleep apnoea. We extracted data from the Finnish Secondary Care Register to assess the incidence of obstructive sleep apnoea, the age and sex distribution, and the prevalence of 26 comorbidities of incident obstructive sleep apnoea patients in Finnish specialized care in 2010 and 2020. Analyses were conducted for three age groups (18 - 39, 40 - 64, and ≥65 years), stratified by sex, and for the total population. From 2010 to 2020, the incidence of clinically diagnosed obstructive sleep apnoea increased from 1.7 to 6.1 per 1000 (from 2.4 to 7.6 per 1000 for men and from 1.0 to 4.6 per 1000 for women). The proportion of the youngest group increased from 11.0% to 12.7% and the oldest group from 20.2% to 27.2%. The largest increase in incidence was observed in the youngest group for both sexes. Among men, the prevalence of six comorbidities decreased, and of eight increased. Among women, the prevalence of seven comorbidities decreased, and of four increased. Obstructive sleep apnoea is being diagnosed increasingly in young adults and those aged 65 years and older. Changes in comorbidities suggest increased recognition and treatment of cardiovascular risk factors and, on the other hand, the ageing of the population. A decrease in some comorbidities suggests that incident obstructive sleep apnoea patients are less morbid despite their increased age.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.